Affinity ultrafiltration of DNA topoisomerases-targeted compounds determined with HPLC/ESI-MS for drug candidate screening.
A method of screening assay is demonstrated. The approach is based on the affinity of antitumor candidates for topoisomerases. In this method, antitumor candidates are fished out using topoisomerases as targets. Traditional analysis of complex compounds typically encounters signal suppression due to the relatively low concentrations, but enzyme-affinity screening for the active compounds can effectively concentrate the desired analysts into a small volume of high concentration. Active compounds are separated from non-affinity compounds by ultrafiltration. The molecules-enzymes complexes that are retained on the filter are subsequently separated by acidification to obtain the topoisomerases-affinity compounds for analysis on High Performance Liquid Chromatography coupled with electrospray ionization mass spectrometric detection (ESI-MS). This enzyme-affinity based screening assay provides a highly specific and efficient method that can directly screen, identify, and acquire drug candidates thus improving the accuracy and speed of high-throughput screening activities.
Zhang
Hong
H
Pan
Yuan-Jiang
YJ
D002851:Chromatography, High Pressure Liquid; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D021241:Spectrometry, Mass, Electrospray Ionization; D059004:Topoisomerase I Inhibitors; D014462:Ultrafiltration
D059004:Topoisomerase I Inhibitors